Indicated for: fungal infections
Substance: posaconazole (azole antifungal)
ATC: J02AC04 (Antiinfectives for systemic use | Antimycotics for systemic use | Triazole derivatives)
Posaconazolum is an antifungal medication used for the prevention and treatment of severe fungal infections, such as invasive aspergillosis or oropharyngeal candidiasis.
It belongs to the triazole class and works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane, leading to fungal destruction.
Posaconazolum is particularly indicated for immunocompromised patients, such as those who have undergone organ transplants or are undergoing chemotherapy.
The medication is available as an oral suspension, tablets, or injectable solution, with the dosage adjusted based on the severity of the infection and the patient's condition.
Common side effects include nausea, diarrhea, headaches, and elevated liver enzyme levels.
In rare cases, more serious adverse effects may occur, such as hepatotoxicity or severe allergic reactions.
It is important for patients to strictly follow their doctor's recommendations and undergo regular liver function tests during treatment.
Posaconazolum may interact with other medications, so patients should inform their doctor about all treatments they are taking.